Last reviewed · How we verify
NCT05449171
High Molecular Weight Hyaluronic Acid, α-lipoic Acid, Magnesium, Vitamin B6 and Vitamin D, in the Prevention of Spontaneous Abortion
NA trial testing high molecular weight hyaluronic acid, α-lipoic acid (ALA), magnesium, vitamin B6 and vitamin D in Abortion, Spontaneous in 100 participants. Completed in 31 January 2024.
1 September 2023
Quick facts
| Lead sponsor | Lo.Li.Pharma s.r.l |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 100 |
| Start date | 1 September 2022 |
| Primary completion | 1 September 2023 |
| Estimated completion | 31 January 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- high molecular weight hyaluronic acid, α-lipoic acid (ALA), magnesium, vitamin B6 and vitamin D
Conditions studied
- Abortion, Spontaneous — all drugs for Abortion, Spontaneous →
Sponsor
Lo.Li.Pharma s.r.l
Who can join
Adults 18 to 45, female only, with Abortion, Spontaneous. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to verify if the association of high molecular weight hyaluronic acid, α-lipoic acid (ALA), magnesium, vitamin B6 and vitamin D, reduces the risk of miscarriage in patients at risk.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05449171
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Abortion, Spontaneous
Currently open trials in the same condition.
- NCT05516810 — The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles · active not recruiting
Other Lo.Li.Pharma s.r.l trials
Trials by the same sponsor.
- NCT07257770 — Local Treatment of Breast Pain Based on the Daily Use of a Topical Gel · NA · recruiting
- NCT06715527 — Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A Comparison · NA · completed
- NCT06639698 — Treatment of Women With PCOS of Phenotype D · NA · completed
- NCT05674318 — The Effect of Alpha-lactalbumin on Microbiota Composition · NA · completed
- NCT05678114 — Inositol Treatment in Different Type of PCOS Phenotype · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05449171 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lo.Li.Pharma s.r.l
- Last refreshed: 22 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05449171.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing